Babcock to test new isolation stretchers for Covid-19 patients
Aviation service Babcock International Group has been authorized by the Italian health and civil aviation authorities to test the use of new isolation stretchers
The IsoArk N36-2 and IsoArk N36-4 biocontainment units for Babcock’s AW139 helicopters will allow the safe transportation of Covid-19 patients while also ensuring the protection of the crew against the virus.
The stretchers are also suitable for use in ground ambulances, meaning it will be easier to collaborate on the transport of severe cases to a number of different locations.
Babcock International Group said in a statement: “Thank you to all our frontline teams for their bravery and selflessness; their safety and the safety of the critically ill patients we are transporting is our top priority and the whole Group is working to support these operations and our staff.”
“We're very pleased to be testing and certifying the new IsoArk biocontainment units that will allow our frontline staff to be better protected in transportation of COVID-19 positive patients.”
Italy continues to report the highest number of Covid-19 cases in Europe. Babcock has flown 1,257 flight hours to deliver 2,615 rescue and patient transport missions.
Editorial Team
The AirMed&Rescue Editorial Team works on the website to ensure timely and relevant news is online every day. With extensive experience and in-depth knowledge of the air medical and air rescue industries, the team is ready to respond to breaking industry news and investigate topics of interest to our readers.